BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22921741)

  • 1. Relative stability of meningococcal serogroup A and X polysaccharides.
    Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
    Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
    Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
    Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.
    Xie O; Bolgiano B; Gao F; Lockyer K; Swann C; Jones C; Delrieu I; Njanpop-Lafourcade BM; Tamekloe TA; Pollard AJ; Norheim G
    Vaccine; 2012 Aug; 30(40):5812-23. PubMed ID: 22835740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.
    Pajon R; Fergus AM; Granoff DM
    PLoS One; 2013; 8(6):e66536. PubMed ID: 23805230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
    Cook MC; Bliu A; Kunkel JP
    Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
    Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
    Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of candidate international standards for meningococcal serogroups A and X polysaccharide.
    Vipond C; Swann CJ; Dougall TW; Rigsby P; Gao F; Beresford NJ; Bolgiano B;
    Biologicals; 2017 May; 47():33-45. PubMed ID: 28389172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
    Micoli F; Romano MR; Tontini M; Cappelletti E; Gavini M; Proietti D; Rondini S; Swennen E; Santini L; Filippini S; Balocchi C; Adamo R; Pluschke G; Norheim G; Pollard A; Saul A; Rappuoli R; MacLennan CA; Berti F; Costantino P
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19077-82. PubMed ID: 24191022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
    Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
    Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation.
    Hlozek J; Kuttel MM; Ravenscroft N
    Carbohydr Res; 2018 Jul; 465():44-51. PubMed ID: 29940397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process development and immunogenicity studies on a serogroup 'X' Meningococcal polysaccharide conjugate vaccine.
    Chilukuri SR; Reddy P; Avalaskar N; Mallya A; Pisal S; Dhere RM
    Biologicals; 2014 May; 42(3):160-8. PubMed ID: 24411634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo determination of Neisseria meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR spectroscopy.
    Gudlavalleti SK; Szymanski CM; Jarrell HC; Stephens DS
    Carbohydr Res; 2006 Mar; 341(4):557-62. PubMed ID: 16406275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China.
    Cook MC; Gibeault S; Filippenko V; Ye Q; Wang J; Kunkel JP
    Biologicals; 2013 Jul; 41(4):261-8. PubMed ID: 23665303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proton nuclear magnetic resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X.
    Garrido R; Puyada A; Fernández A; González M; Ramírez U; Cardoso F; Valdés Y; González D; Fernández V; Vérez V; Vélez H
    J Pharm Biomed Anal; 2012 Nov; 70():295-300. PubMed ID: 22877873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design.
    Pietri GP; Bertuzzi S; Karnicar K; Unione L; Lisnic B; Malic S; Miklic K; Novak M; Calloni I; Santini L; Usenik A; Romano MR; Adamo R; Jonjic S; Turk D; Jiménez-Barbero J; Lenac Rovis T
    Carbohydr Polym; 2024 Oct; 341():122349. PubMed ID: 38876728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
    Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
    J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of meningococcal serogroups in formulated monovalent and multivalent polysaccharide and polysaccharide-conjugate vaccines.
    Cook MC; Kunkel JP
    Anal Chem; 2015 May; 87(9):5009-11. PubMed ID: 25837841
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A.
    Torres-Sanchez MI; Zaccaria C; Buzzi B; Miglio G; Lombardi G; Polito L; Russo G; Lay L
    Chemistry; 2007; 13(23):6623-35. PubMed ID: 17508372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.